About the journal
Molecular Oncology is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,730 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 1574-7891 · 1878-0261
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,730 USD
- Articles in DOAJ
- 1756
- Declared review time
- 10 weeks
- Declared peer-review model
- open_review
- Official website
- https://febs.onlinelibrary.wiley.com/journal/18780261
Index listings
- DOAJ · 2017-10-27
- MEDLINE · 2007-01-01
- PUBMED · 2010-04-14
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 4,730 USD
- Declared review time (DOAJ)
- 10 weeks
- Actual review time (measured)
- 139 days received→accepted — computed from PubMed (n=89)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1756
Most recent article
last month
Average review time (journal-declared via DOAJ)
10weeks
Works in OpenAlex
3227
Last recorded publication year
2026
h-index
149
i10-index
1878
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2017-10-27
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 84%
- ORCID iDs in current deposits
- 83%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101308230
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Cells and Metastasis
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Cells and Metastasis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Show all subjects (50)
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- RNA Research and Splicing
- RNA Research and Splicing
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Educational Robotics and Engineering
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Circular RNAs in diseases
- Circular RNAs in diseases
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Keywords (DOAJ)
- cancer
- molecular biology
- molecular genetics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ